Galmed Pharmaceuticals Stock Analysis - Period Momentum Indicator
| GLMD Stock | USD 0.63 0.04 6.78% |
Period Momentum Indicator measures the change between the current price and an earlier reference price, showing the speed of recent movement.
Period Momentum Indicator Analysis Today
Period Momentum Indicator measures the change between the current price and an earlier reference price, showing the speed of recent movement. The current Period Momentum Indicator for Galmed Pharmaceuticals is 0.04. This reading indicates consistent price behavior relative to the prior session.| Volatility | Backtest | Information Ratio |
Galmed Pharmaceuticals Trading Date Momentum
| On May 07 2026 Galmed Pharmaceuticals was traded for 0.63 at the closing time. The top price for the day was 0.66 and the lowest listed price was 0.62 . The trading volume for the day was 126.2 K. The trading history from May 7, 2026 remained within defined bounds. The net trading delta against the current closing price is -1.59% . |
Sustained high positive momentum indicates strong upward velocity; sustained negative momentum indicates persistent selling pressure. Extreme readings over extended periods may indicate overbought or oversold conditions.
| Compare Galmed Pharmaceuticals to competition |
Related Price-Series Methods for Galmed Pharmaceuticals
These methods summarize the same price history through smoothing, range, and momentum calculations. Reviewing them alongside Period Momentum Indicator helps compare stable sessions with periods of wider price movement in Galmed Pharmaceuticals.Galmed Pharmaceuticals Related Equities
These firms work in a similar space as Galmed Pharmaceuticals within the Health Care space and serve as useful points for comparison. Market cap and total value checks frame Galmed Pharmaceuticals' size within the competitive field. Identifying peers that steadily beat or lag Galmed Pharmaceuticals across many periods highlights durable competitive gaps.
| Risk & Return | Correlation |
Galmed Pharmaceuticals Market Strength Events
Rate of Change and Momentum readings for Galmed Pharmaceuticals measure the velocity of recent price moves rather than direction alone. These indicators add context to how recent sessions in Galmed Pharmaceuticals have behaved.
Galmed Pharmaceuticals Risk Indicators
Standard deviation and variance for Galmed Pharmaceuticals measure total price dispersion, while semi-deviation isolates only the downside moves. Higher variance relative to sector peers signals that Galmed Pharmaceuticals' price path has been less predictable over the measured period.
| Mean Deviation | 4.38 | |||
| Semi Deviation | 4.88 | |||
| Standard Deviation | 6.22 | |||
| Variance | 38.64 | |||
| Downside Variance | 30.25 | |||
| Semi Variance | 23.79 | |||
| Expected Short fall | -5.45 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Galmed Pharmaceuticals Short Properties
Short sentiment tied to Galmed Pharmaceuticals matters because heavier bearish pressure can change how quickly future price expectations become unstable. The practical goal is to identify when the balance between long and short participation may be changing the quality of the setup.
| Common Stock Shares Outstanding | 4.31 million | |
| Cash And Short Term Investments | 18.16 million |